Cancer can now be treated using living cells and synthetic biology, researchers found

Northwestern University synthetic biologist Joshua Leonard and his team have developed a design process that uses parts from a different type of device to build complex genetic cycles for cell engineering. The use of live cells as medicines is very useful in medicine. Many patients have been treated with this new approach. This new discovery would help the bioengineers to make genetic programs using synthetic biology.

Computational modeling to identify genetic design

These advances use a growing range of synthetic biology methods that use tools and concepts from biology and engineering. Northwestern University is now using computer modeling to identify useful genetic designs before building them in the laboratory. The study was published on Feb. 19 in the journal Science Advances with dozens of genetic cycles designed and tested.

Read: FIFA 21: Research shows that 56% of people have meaningful conversations after playing FIFA

Read: TNAU, Nigerian Institute of Banana Research Ink Agreement

Northwestern University synthetic biologist Joshua Leonard said, “To invent a cell, we first encode the biological function you want into a piece of DNA, and that DNA program is delivered to a human cell to produce instructions for the action you want, such as execution. gene only in response to specific signals in the cell environment ”. For this study, Joshua Leonard led a team of researchers from Northwestern University in collaboration with Neda Bagheri from the University of Washington. This discovery helps bioengineers to perform genetic programs using synthetic biology.

Read: Ganga River could spill 3 billion microplastic parts into Bengal Bay: Research

Read: Stop ‘pollution crime’, NGT tells Govt about sewage discharges in rivers joining Ganga

Researchers used a “toolkit” of genetic components

A key feature of this approach is that it is expected to be easily adopted by other bioengineering organizations. The research team used a “toolkit” of genetic components created in the laboratory and paid for these parts with computer tools to stimulate many genetic programs before testing. Researchers have found that a wide variety of genetic programs perform a useful and beneficial function in human cells. They can be built in such a way that each program works as intended.